Entero Healthcare Solutions Limited will host an investor conference on September 2, 2026, at 3:00 pm in Mumbai. The company disclosed the schedule under SEBI Listing Obligations and Disclosure Requirements Regulations 2015.

The interaction is organized by Elara Capital and will take place in a physical format. Company officials will participate in both one-on-one and group meetings with analysts and institutional investors.

Event Details

Discussions during the conference will be based strictly on publicly available information. The company stated that no unpublished price-sensitive information (UPSI) is intended to be discussed.

Sanu Kapoor, Vice President- Group General Counsel, Company Secretary & Compliance Officer, signed the intimation letter dated August 24, 2026. The company noted that changes to the schedule may occur due to exigencies on the part of participants or the company.

Entero Healthcare Solutions announced that Mr. Rajesh Shashikant Dalal ceases to serve as an Independent Director effective August 24, 2026. The departure follows the completion of his tenure with the company.

The intimation was issued under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure builds upon previous notifications dated July 13, 2026, and August 7, 2026.

Committee Roles

Mr. Dalal (DIN: 03504969) simultaneously steps down from key board committee positions. He ceases to be the Chairperson of the Nomination and Remuneration Committee and the Stakeholders Relationship Committee. He also resigns as a member of the Audit Committee.

These changes take effect from the close of business hours on August 24, 2026.

Corporate Governance

The company acknowledged Mr. Dalal’s contributions during his tenure as a Non-Executive Independent Director. Sanu Kapoor, Vice President - Group General Counsel, Company Secretary & Compliance Officer, signed the disclosure letter.